Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 943 results for "novartis"

Novartis heart failure drug available via EAMS
Pharmafile

Novartis heart failure drug available via EAMS

Entresto is available to patients with heart failure through the MHRA's market access scheme Novartis has won the investigational heart failure treatment LCZ696 (sacubitril valsartan) will be available in the UK under the Early Access to ... Pharmafile, 18 hours ago
Heart failure medicine LCZ696 to be available to the NHS European Pharmaceutical Review, 1 day ago
EAMS makes Novartis heart failure medicine available to NHS European Pharmaceutical Manufacturer, 1 day ago
[x]  
Pharmafile

Novartis marks US launch of 'biosimilar' drug

Novartis kicked off a new era in US medicine on Thursday with the launch of the first 'biosimilar' copy of a biotechnology drug approved in the United States, following a green light from a US appeals court. Novartis unit Sandoz said Zarxio, its form of ...
 Deccan Herald17 hours ago Novartis makes history with US launch of biosimilar drug  Business Line1 day ago Sandoz launches first US biosimilar  Pharmafile23 hours ago Novartis makes history with U.S. biosimilar launch  TeleTrader.com1 day ago
[x]  
Bidness Etc

Amgen, Inc. Fails To Block Novartis AG (ADR) From Launching Biosimilar

A federal appeals court on Wednesday rejected Amgen Inc.'s ( NASDAQ:AMGN ) request for a temporary injunction to block Novartis AG (ADR) ( NYSE:NVS ) from launching a biosimilar version of Amgen's blockbuster drug, Neupogen, in the US. According ...
 Bidness Etc22 hours ago Novartis Neupogen Biosimilar: On Sale Now  Pharmaceutical Manufacturing Magazine14 hours ago US biosimilar era officially dawns as Novartis' Zarxio launches Thursday  BioPharma Dive18 hours ago Morning Read: UAW proposes healthcare Co-Op, Novartis launches biosimilar drug in U.S. to boost white blood cell count  MedCity News21 hours ago
TheStreet.com

Amgen (AMGN) Stock Falls as Novartis Begins Selling Biosimilar Version of Neupogen

Reddit Email Print Reprint NEW YORK ( TheStreet ) -- Amgen ( AMGN - Get Report ) shares are down 1.5% to $150 in afternoon trading on Thursday after rival Novartis ( NVG ) launched abiosimilar version of Amgen's Neupogen treatment. ...
 TheStreet.com15 hours ago Should You Buy Amgen Stock? 3 Pros, 3 Cons (AMGN)  InvestorPlace.com1 day ago
FOXNews.com

Some leukemia patients see durable results from Novartis therapy

Some leukemia patients who had exhausted other treatment options have no trace of the disease more than four years after being treated with an experimental type of therapy called CAR T cells in a small pilot study at the University of Pennsylvania. ...
 FOXNews.com22 hours ago Some leukemia patients see durable...  LocalNews7.com17 hours ago
Channel NewsAsia

Novartis launches Neupogen copycat Zarxio in US market

The move came after a US appeals court declined on Wednesday to stop the sale of the company's copycat version of Amgen Inc's blockbuster cancer drug Neupogen.
 Economic Times1 day ago Amgen cannot stop imminent sale of Neupogen copycat: US appeals court  Channel NewsAsia1 day ago Novartis launches Zarxio in the U.S.  TeleTrader.com23 hours ago Appeals court clears the way for Novartis' U.S. launch of Zarxio  TeleTrader.com1 day ago
[x]  
Bio Spectrum Asia

Novartis, Amgen collaborate to develop drugs for Alzheimer's...

 Bio Spectrum Asia1 day ago FLXN On Fast Track, WMGI Gets FDA Nod, RDHL Gearing Up, NVRO Awaits D-Day  RTTNews.com2 days ago Amgen to Help Develop Novartis's Pipeline of Alzheimer's Drugs  FOXBusiness.com2 days ago Amgen, Novartis collaborate for Alzheimer's disease and migraine programs  9ija News.com2 days ago
Business Today India

Stocks that made news today: Godrej, Bharti Airtel and more

Novartis India : Novartis India on Friday said it has received FIPB approval to sell its OTC division to GlaxoSmithKline Consumer Pvt Ltd (GSK CPL) and will now proceed to complete the transaction. The Foreign Investment Promotion Board (FIPB) has ...
 Business Today India4 days ago Novartis India gains after FIPB nod to transfer OTC division  Business Standard4 days ago Stocks in news: MM, Novartis, Godrej Cons, Bharti, Astec  Money Control4 days ago Novartis India updates on proposed transfer of its OTC division  Business Standard6 days ago
[x]  
Business Insider

Novartis, Amgen join forces to fight Alzheimer's and migraine

LONDON (Reuters) - Novartis and Amgen are joining forces in the hunt for an Alzheimer's treatment, in the latest sign that drugmakers believe an effective therapy for the memory-robbing disease may be within reach. The two companies also plan to ...
 Business Insider2 days ago Novartis and Amgen team up to take on Alzheimer's, migraines  BioPharma Dive1 day ago Novartis continues commitment to go the last mile in effort to eliminate leprosy  EuroInvestor1 week ago Novartis completes divestiture of influenza vaccines business...  Bio Spectrum Asia1 week ago
[x]  
Motley Fool

GlaxoSmithKline Lines Its Pockets Courtesy of Novartis Once Again

For many Big Pharma companies the worst of the patent cliff is over. Within the last couple of years we've witnessed true heavy-hitting drugs, such as cholesterol-lowering drug Lipitor and asthma therapy Singulair, lose their exclusivity and have ...
 Motley Fool1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - novartis
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less